Table 5

Physician Continuity and Medication Usage in Patients Age ≥65 Years

Physician Continuity During First 30 DaysTotal (n = 9,951)p Value
One or More Visits With Familiar Physician(s) (n = 6,783)All Visits With Unfamiliar Physician(s) (n = 1,060)No Visits (n = 2,108)
Age, yrs79.0 ± 7.579.3 ± 8.181.3 ± 8.279.5 ± 7.8<0.0001
Medications in 90 days up to and including index ED visit
 ACE-I/ARB3,762 (55.5)503 (47.5)944 (44.8)5,209 (52.3)<0.0001
 BB2,590 (38.2)319 (30.1)552 (26.2)3,461 (34.8)<0.0001
 ACE-I/ARB and BB1,800 (26.5)217 (20.5)392 (18.6)2,409 (24.2)<0.0001
 Diuretic3,820 (56.3)536 (50.6)1,068 (50.7)5,424 (54.5)<0.0001
 Digoxin1,175 (17.3)131 (12.4)336 (15.9)1,642 (16.5)0.0002
 Statin1,699 (25.0)218 (20.6)319 (15.1)2,236 (22.5)<0.0001
Medications in 90 days after index ED visit
 ACE-I/ARB4,443 (65.5)626 (59.1)1,028 (48.8)6,097 (61.3)<0.0001
 BB2,698 (39.8)355 (33.5)510 (24.2)3,563 (35.8)<0.0001
 ACE-I/ARB and BB2,102 (31.0)265 (25.0)386 (18.3)2,753 (27.7)<0.0001
 Diuretic5,543 (81.7)848 (80.0)1,355 (64.3)7,746 (77.8)<0.0001
 Digoxin1,450 (21.4)198 (18.7)374 (17.7)2,022 (20.3)0.0005
 Statin1,759 (25.9)225 (21.2)313 (14.8)2,297 (23.1)<0.0001

Values are mean ± SD or n (%).

ACE-I = angiotensin-converting enzyme inhibitor; ARB = angiotensin receptor blocker; BB = beta-blocker; other abbreviation as in Table 1.